» Articles » PMID: 28628823

Drug Development Against Tuberculosis: Impact of Alkaloids

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2017 Jun 20
PMID 28628823
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Despite of the advances made in the treatment and management, tuberculosis (TB) still remains one of main public health problem. The contrary effects of first and second-line anti-tuberculosis drugs have generated extended research interest in natural products in the hope of devising new antitubercular leads. Interestingly, plethoras of natural products have been discovered to exhibit activity towards various resistant strains of M. tuberculosis. Extensive applications of alkaloids in the field of therapeutics is well-established and nowday's researches being pursued to develop new potent drugs from natural sources for tuberculosis. Alkaloids are categorized in quite a few groups according to their structures and isolation from both terrestrial and marine sources. These new drugs might be a watershed in the battle against tuberculosis. This review summarizes alkaloids, which were found active against Mycobacteria since last ten years with special attention on the study of structure-activity relationship (SAR) and mode of action with their impact in drug discovery and development against tuberculosis.

Citing Articles

Discovery of anti-Mycobacterium tuberculosis desertomycins from Streptomyces flavofungini TRM90047 based on genome mining and HSQC-TOCSY.

Wang L, Reheman A, Wan C Sci Rep. 2024; 14(1):17006.

PMID: 39043745 PMC: 11266358. DOI: 10.1038/s41598-024-65702-0.


Isoflavonoid and Furanochromone Natural Products as Potential DNA Gyrase Inhibitors: Computational, Spectral, and Antimycobacterial Studies.

Jagatap V, Ahmad I, Sriram D, Kumari J, Kwabena Adu D, Ike B ACS Omega. 2023; 8(18):16228-16240.

PMID: 37179626 PMC: 10173323. DOI: 10.1021/acsomega.3c00684.


Screening of Microbial Fermentation Products for Anti- Activity.

Reheman A, Lu D, Wang Y, Chen X, Cao G, Wan C Animals (Basel). 2022; 12(15).

PMID: 35953936 PMC: 9367595. DOI: 10.3390/ani12151947.


Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling.

Boussamba-Digombou K, Sandasi M, Kamatou G, van Vuuren S, Sawicki R, Fakhar Z Antibiotics (Basel). 2022; 11(7).

PMID: 35884202 PMC: 9311982. DOI: 10.3390/antibiotics11070948.


Evaluation of in vitro susceptibility to sparteine in four strains of Mycobacterium tuberculosis.

Hidalgo M, Asmat Marrufo P, Lezama Asencio P, Ramos C, Chimoy Tunoque C, Zolla G Rev Peru Med Exp Salud Publica. 2022; 39(1):77-82.

PMID: 35766744 PMC: 11397676. DOI: 10.17843/rpmesp.2022.391.10136.